Paul Schimmel

Paul Schimmel

Oprichter bij
Reactive Biosciences, Inc.

Vermogen: 1 M $ op 30-06-2026

85 jaar
Health Technology
Commercial Services
Finance

Profiel

Paul R.
Schimmel
was the founder of Reactive Biosciences, Inc. (founded 2021), Alkermes, Inc. (founded 1987), Metabolon, Inc. (founded 2000), Abide Therapeutics, Inc. (founded 2011; Director), aTyr Pharma, Inc. (founded 2005; Independent Director), Repligen Corp.
(founded 1981; Co-Chairman), Alnylam Pharmaceuticals, Inc. (founded 2002; Independent Director), Momenta Pharmaceuticals, Inc. (founded 2001; Director), and Sirtris Pharmaceuticals, Inc. (founded 2004; Director).
Dr. Schimmel is also the founder of Cubist Pharmaceuticals LLC..
Current positions include Director at KinDex Pharmaceuticals, Inc. and Tevard Biosciences, Inc., Professor at The Scripps Research Institute (since 1997) and Skaggs Institute For Chemical Biology, Member of the National Academy of Sciences, National Academy of Medicine (United States), National Academy of Inventors, American Academy of Arts & Sciences, American Philosophical Society, and National Academy of Medicine, Advisor at Longwood Fund Management LLC, and Venture Partner at CHP Management, Inc. Former positions include Chairman of the Biological Chemistry Division at the American Chemical Society, Director at Momenta, Inc., Independent Director at Tocagen, Inc. (2015–2020), Director at Avicena Group, Inc., Vividion Therapeutics, Inc., and Alkermes Plc, Professor at Massachusetts Institute of Technology, and Member of the Scientific Advisory Board at Illumina, Inc. Education includes a doctorate from Cornell University, a doctorate from Massachusetts Institute of Technology (1966), and undergraduate studies at Ohio Wesleyan University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
27-05-2026 2.201.056 ( 2,24% ) 1 M $ 30-06-2026

Actieve functies van Paul Schimmel

BedrijvenFunctieBegin
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Private Equity Investor -
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Bestuurslid -
Oprichter 01-01-2021
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Eerdere bekende functies van Paul Schimmel

BedrijvenFunctieEinde
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Ervaring van Paul Schimmel in detail bekijken

Opleiding van Paul Schimmel

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

75

Eerstegraads connecties

32

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Finance

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Distribution Services

National Academy of Medicine

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Skaggs Institute For Chemical Biology

  1. Beurs
  2. Insiders
  3. Paul Schimmel